BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Prognosis
36 results:

  • 1. BACH1 promotes lung adenocarcinoma cell metastasis through transcriptional activation of ITGA2.
    Chen Y; Jin L; Ma Y; Liu Y; Zhu Q; Huang Y; Feng W
    Cancer Sci; 2023 Sep; 114(9):3568-3582. PubMed ID: 37311571
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of rac1 in promoting brain metastasis of lung adenocarcinoma using single-cell transcriptome sequencing.
    Chen M; Li H; Xu X; Bao X; Xue L; Ai X; Xu J; Xu M; Shi Y; Zhen T; Li J; Yang Y; Ji Y; Fu Z; Xing K; Qing T; Wang Q; Zhong P; Zhu S
    Cell Death Dis; 2023 May; 14(5):330. PubMed ID: 37202394
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. FMRP ligand circZNF609 destabilizes rac1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma.
    Shang Q; Du H; Wu X; Guo Q; Zhang F; Gong Z; Jiao T; Guo J; Kong Y
    J Exp Clin Cancer Res; 2022 May; 41(1):170. PubMed ID: 35534866
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma.
    Mao CG; Jiang SS; Wang XY; Tao SL; Jiang B; Mao CY; Yang YL; Hu ZY; Long T; Jin H; Tan QY; Huang Y; Deng B
    Int J Biol Sci; 2021; 17(10):2461-2475. PubMed ID: 34326687
    [No Abstract]    [Full Text] [Related]  

  • 5. rac1-mediated sustained β4 integrin level develops reattachment ability of breast cancer cells after anchorage loss.
    Mori K; Higurashi M; Ishikawa F; Shibanuma M
    Cancer Sci; 2021 Aug; 112(8):3205-3217. PubMed ID: 34036687
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CERS6 required for cell migration and metastasis in lung cancer.
    Suzuki M; Cao K; Kato S; Mizutani N; Tanaka K; Arima C; Tai MC; Nakatani N; Yanagisawa K; Takeuchi T; Shi H; Mizutani Y; Niimi A; Taniguchi T; Fukui T; Yokoi K; Wakahara K; Hasegawa Y; Mizutani Y; Iwaki S; Fujii S; Satou A; Tamiya-Koizumi K; Murate T; Kyogashima M; Tomida S; Takahashi T
    J Cell Mol Med; 2020 Oct; 24(20):11949-11959. PubMed ID: 32902157
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. HACE1 Prevents lung Carcinogenesis via Inhibition of RAC-Family GTPases.
    Kogler M; Tortola L; Negri GL; Leopoldi A; El-Naggar AM; Mereiter S; Gomez-Diaz C; Nitsch R; Tortora D; Kavirayani AM; Gapp BV; Rao S; Uribesalgo I; Hoffmann D; Cikes D; Novatchkova M; Williams DA; Trent JM; Ikeda F; Daugaard M; Hagelkruys A; Sorensen PH; Penninger JM
    Cancer Res; 2020 Jul; 80(14):3009-3022. PubMed ID: 32366477
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma.
    Jin R; Wang X; Zang R; Liu C; Zheng S; Li H; Sun N; He J
    Cancer Lett; 2020 Jul; 483():46-58. PubMed ID: 32272148
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. LncRNA NR2F2-AS1 Upregulates rac1 to Increase cancer Stemness in Clear Cell Renal Cell Carcinoma.
    Chen L; Zhang D; Ding T; Liu F; Xu X; Tian Y; Xiao J; Shen H
    Cancer Biother Radiopharm; 2020 May; 35(4):301-306. PubMed ID: 32109138
    [No Abstract]    [Full Text] [Related]  

  • 11. Proteoglycan serglycin promotes non-small cell lung cancer cell migration through the interaction of its glycosaminoglycans with CD44.
    Guo JY; Chiu CH; Wang MJ; Li FA; Chen JY
    J Biomed Sci; 2020 Jan; 27(1):2. PubMed ID: 31898491
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long noncoding RNA LCAT1 functions as a ceRNA to regulate rac1 function by sponging miR-4715-5p in lung cancer.
    Yang J; Qiu Q; Qian X; Yi J; Jiao Y; Yu M; Li X; Li J; Mi C; Zhang J; Lu B; Chen E; Liu P; Lu Y
    Mol Cancer; 2019 Nov; 18(1):171. PubMed ID: 31779616
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
    Ji Z; Pan X; Shang Y; Ni DT; Wu FL
    Tissue Cell; 2019 Dec; 61():44-50. PubMed ID: 31759406
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. GAP43, a novel metastasis promoter in non-small cell lung cancer.
    Zhang F; Ying L; Jin J; Feng J; Chen K; Huang M; Wu Y; Yu H; Su D
    J Transl Med; 2018 Nov; 16(1):310. PubMed ID: 30419922
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell lung cancer.
    Aboubakar Nana F; Lecocq M; Ladjemi MZ; Detry B; Dupasquier S; Feron O; Massion PP; Sibille Y; Pilette C; Ocak S
    Mol Cancer Ther; 2019 Jan; 18(1):17-27. PubMed ID: 30352800
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Critical role of the Ror-family of receptor tyrosine kinases in invasion and proliferation of malignant pleural mesothelioma cells.
    Saji T; Nishita M; Ogawa H; Doi T; Sakai Y; Maniwa Y; Minami Y
    Genes Cells; 2018 Jul; 23(7):606-613. PubMed ID: 29845703
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ARHGEF39 promotes tumor progression via activation of rac1/P38 MAPK/ATF2 signaling and predicts poor prognosis in non-small cell lung cancer patients.
    Zhou H; Cai L; Zhang X; Li A; Miao Y; Li Q; Qiu X; Wang E
    Lab Invest; 2018 May; 98(5):670-681. PubMed ID: 29382922
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma.
    Wang X; Xu W; Zhan P; Xu T; Jin J; Miu Y; Zhou Z; Zhu Q; Wan B; Xi G; Ye L; Liu Y; Gao J; Li H; Lv T; Song Y
    J Cell Mol Med; 2018 Apr; 22(4):2177-2189. PubMed ID: 29377583
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Effect of miR‑146a‑5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation.
    Huang WT; Cen WL; He RQ; Xie Y; Zhang Y; Li P; Gan TQ; Chen G; Hu XH
    Mol Med Rep; 2017 Dec; 16(6):8781-8792. PubMed ID: 28990079
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ITIH5 mediates epigenetic reprogramming of breast cancer cells.
    Rose M; Kloten V; Noetzel E; Gola L; Ehling J; Heide T; Meurer SK; Gaiko-Shcherbak A; Sechi AS; Huth S; Weiskirchen R; Klaas O; Antonopoulos W; Lin Q; Wagner W; Veeck J; Gremse F; Steitz J; Knüchel R; Dahl E
    Mol Cancer; 2017 Feb; 16(1):44. PubMed ID: 28231808
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.